🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Status
Withdrawn
Location
NL-Amsterdam-VUMC
Start Date
2022-01
Trial ID
NCT05063123
Treatments Being Tested
The investigators hypothesize that flotetuzumab for relapsed AML following ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2021-05-20
Trial ID
NCT04582864
Treatments Being Tested
The purpose of this research study is to determine if the study drug, flote...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2022-10-20
Trial ID
NCT05506956
Treatments Being Tested
The purpose of the Expanded Access program is to provide flotetuzumab to pa...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04678466
Treatments Being Tested
This phase I trial studies the best dose and side effects of flotetuzumab f...
Status
Completed
Location
City of Hope Medical Center
Start Date
2020-11-18
Trial ID
NCT04681105
Treatments Being Tested
Open-label, multi-dose, single-arm, multi-center, Phase 1/2 study conducted...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2014-06-09
Trial ID
NCT02152956
Treatments Being Tested
This phase I trial studies the side effects, best dose of flotetuzumab and ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-01-22
Trial ID
NCT04158739
Treatments Being Tested
This phase II trial studies how well flotetuzumab works in treating patient...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-20
Trial ID
NCT03739606
Treatments Being Tested